Today: 11 June 2026
D-Wave Quantum stock today: QBTS on hold as New Year’s shutdown shifts focus to January catalysts
1 January 2026
2 mins read

D-Wave Quantum stock today: QBTS on hold as New Year’s shutdown shifts focus to January catalysts

NEW YORK, January 1, 2026, 06:01 ET — Market closed

D-Wave Quantum Inc shares were last at $26.15, down 0.4% from the prior close after a volatile final trading day of 2025, with U.S. stock markets shut on Thursday for the New Year’s Day holiday.

The pause matters because many quantum-computing names have traded like high-beta “theme” stocks, swinging with risk appetite and liquidity rather than day-to-day company news. Trading resumes on Friday, when investors typically get their first read on how much year-end positioning carried into January. Nasdaq

Macro data are also back in focus after a late-December drop in U.S. jobless claims added to debate over how quickly the Federal Reserve can keep cutting rates in early 2026. “The drop in initial unemployment claims to 199,000 in the week of Christmas was likely another seasonal-adjustment distortion,” John Ryding, chief economic adviser at Brean Capital, said in a Reuters report. Reuters

Peers were also slightly lower at the last U.S. close, with IonQ down about 0.9%, Rigetti Computing off about 1.1% and Quantum Computing Inc down about 1.3%.

Next week brings fresh macro signals, starting with the Institute for Supply Management’s manufacturing PMI report on Monday and services PMI on Wednesday. Those releases can move rate expectations and, by extension, speculative growth stocks that are sensitive to discount-rate swings.

Investors also have the U.S. employment report on January 9 on the calendar, another key input for the Fed outlook and market volatility.

On the company side, D-Wave has near-term visibility events that traders will watch for sentiment and customer chatter. The company said it will participate in CES 2026 as a sponsor of the CES Foundry on January 7-8 in Las Vegas, including a scheduled masterclass and demo on January 7.

Later in the month, D-Wave said its Qubits 2026 user conference will run January 27-28 in Boca Raton, Florida, where it plans to discuss its product roadmap and progress across both annealing and gate-model quantum computing.

D-Wave sells access to its quantum systems and tools, including its Advantage system and the Leap cloud service, and it positions its approach around “quantum annealing,” a method tailored to optimization problems such as scheduling and routing. MarketBeat noted that pure-play quantum stocks often trade as speculative, high-volatility bets whose returns hinge on the pace of commercialization. MarketBeat

Wall Street’s published stance remains broadly constructive. A MarketBeat compilation put D-Wave’s average brokerage recommendation at “Moderate Buy,” with a one-year consensus price target of about $33.67. MarketBeat

Before the next session, traders will be watching whether QBTS holds the $26 area after the latest day’s range between roughly $26 and $27.4, with a break above the recent high likely drawing momentum buyers and a slip below recent lows risking a deeper pullback.

The next hard catalyst on the calendar is earnings. MarketBeat estimates D-Wave’s next results around March 12, while noting the company has not confirmed a publication date; investors will be looking for revenue traction and signs that cash burn is tracking with management’s growth plans.

Stock Market Today

  • BeOne Medicines (ONC) RSI Falls Below 30, Hits Oversold Territory
    June 11, 2026, 5:22 PM EDT. BeOne Medicines Ltd (ONC) shares entered oversold territory Thursday with a Relative Strength Index (RSI) reading of 28.9, below the 30 threshold signaling potential exhaustion of selling pressure. The RSI measures momentum on a scale from 0 to 100, where below 30 indicates oversold conditions. ONC shares traded as low as $253.95, near their 52-week low of $239.25, compared to a 52-week high of $385.22. By contrast, the S&P 500 ETF (SPY) RSI stands at 51.5, suggesting balanced market momentum. Investors may view ONC's oversold status as a buying opportunity, consistent with Warren Buffett's advice to be greedy when others are fearful. ONC last traded at $260.31.

Latest articles

Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

11 June 2026
Moderna surged 7.94% to $49.64 as U.S. stocks rebounded sharply, with investors eyeing its mRNA cancer-vaccine pipeline after a UK trial authorization; Wall Street’s average analyst rating remains “Hold” with a $43.30 target, and BofA raised its price target to $34 citing norovirus prospects, while Moderna reported Q1 revenue of $389 million and a $1.3 billion net loss.
B2Gold shares move up as gold helps lift TSX miners

B2Gold shares move up as gold helps lift TSX miners

11 June 2026
B2Gold shares soared over 5% on both NYSE American and TSX as gold prices rebounded and investors piled into Canadian mining stocks, with the company’s strong sensitivity to bullion prices and recent leadership change fueling the rally; trading volume topped 32 million shares and B2Gold outperformed the TSX index.
Bitmine’s BMNR Stock Gains After Preferred Sale Wraps, Ethereum Move Draws Eyes

Bitmine’s BMNR Stock Gains After Preferred Sale Wraps, Ethereum Move Draws Eyes

11 June 2026
Bitmine Immersion Technologies jumped 5.6% to $16.52 after issuing 3.5 million shares of 9.50% Series A Perpetual Preferred Stock, raising about $273.8 million for potential Ethereum purchases and staking expansion; the company now holds 5.54 million ETH, equal to 4.59% of Ethereum’s supply, and its price action remains closely tied to ETH moves.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop